4 completed, 1 terminated. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Terminated 1 |
Follow Tranzyme, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Diabetic Gastroparesis Efficacy/Safety Study of TZP-102 10 mg TZP-102, Placebo - Diabetic Gastroparesis | Phase 2 | Terminated | Tranzyme, Inc. | 120 | 2012-08-01 | 2012-12-20 |
| Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis Placebo, 10mg TZP-102, 20mg TZP-102 - Gastroparesis, Diabetes Mellitus, Type 1 | Phase 2 | Completed | Tranzyme, Inc. | 201 | 2011-09-01 | 2013-04-25 |
| Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus TZP-102, Placebo - Gastroparesis, Diabetes Mellitus | Phase 2 | Completed | Tranzyme, Inc. | 92 | 2009-04-01 | 2012-12-11 |
| Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis 5% dextrose in water, TZP-101 - Gastroparesis, Diabetes Mellitus | Phase 2 | Completed | Tranzyme, Inc. | 78 | 2007-10-01 | 2012-12-07 |
| Safety and Efficacy of IV Infusion of TZP-101 for POI After Major Open Abdominal Surgery 5% dextrose in water, TZP-101 - Postoperative Ileus | Phase 2 | Completed | Tranzyme, Inc. | 267 | 2007-07-01 | 2012-12-07 |
Gastroparesis (4) · Diabetes Mellitus (2) · Diabetes Mellitus, Type 1 (2) · Diabetes Mellitus, Type 2 (2)
Glucose (2) · Water (2) · ulimorelin (2)
United States (5) · Denmark (3) · Norway (3) · Poland (3) · Sweden (3) · India (2) · United Kingdom (2) · Belgium (1) · Finland (1) · Germany (1) · Romania (1)
Connie Cosentino (1) · Elsa Mondou, M.D. (1)